期刊文献+

FUNDC1基因沉默对卵巢癌SKOV3细胞增殖和侵袭的影响 被引量:6

Effects of silencing FUNDC1 gene on proliferation and invasion of ovarian cancer cell SKOV3
下载PDF
导出
摘要 目的探讨FUNDC1蛋白在卵巢癌组织中的表达及其对卵巢癌细胞增殖和侵袭的影响。方法通过免疫组织化学(S-P法)检测FUNDC1蛋白在卵巢癌组织中的表达;流式细胞仪检测卵巢癌SKOV3细胞沉默FUNDC1基因后细胞周期的变化;Ed U检测卵巢癌SKOV3细胞沉默FUNDC1基因后细胞增殖能力变化;Transwell检测卵巢癌SKOV3细胞侵袭能力;Western blotting检测p21和p53蛋白的表达。结果 FUNDC1蛋白在卵巢癌组织细胞质中表达;在卵巢癌组织中FUNDC1蛋白呈阳性表达,在正常卵巢组织中FUNDC1蛋白呈弱阳性或不表达。与正常卵巢组织相比,FUNDC1蛋白在卵巢癌组织中的表达明显增高(P=0.021);FUNDC1蛋白在晚期卵巢癌(Ⅲ/Ⅳ期)组织中的表达明显高于早期卵巢癌(Ⅰ/Ⅱ期)组织,差异有统计学意义(P=0.012)。沉默卵巢癌SKOV3细胞FUNDC1基因后,卵巢癌细胞增殖能力(P=0.032)和侵袭能力(P=0.035)降低,S期细胞明显减少(P=0.015),p21和p53蛋白表达上调。结论 FUNDC1蛋白在卵巢癌组织中的表达上调,FUNDC1调控卵巢癌SKOV3细胞增殖可能和p53/p21途径有关。 Objective To explore the expression of FUNDC1 protein in tissues of ovarian cancer and its effects on proliferation and invasion of ovarian cancer cells.Methods The expression of FUNDC1 protein in tissues of ovarian cancer was detected by immunohistochemical(S-P method).Changes of the cell cycle of ovarian cancer cell SKOV3 were detected by flow cytometry after the FUNDC1 gene was silenced.The abilities of proliferation and invasion of ovarian cancer cell SKOV3 were detected by EdU assay and Transwell assay,respectively.Western blotting was used to detect the expressions of p21 and p53 proteins.Results FUNDC1 expressed in the cytoplasm of ovarian cancer tissues.FUNDC1 positively expressed in tissues of ovarian cancer,while showed weakly positive or negative expression in normal ovarian tissues.Compared with normal ovarian tissues,the expression of FUNDC1 in ovarian cancer tissues was significantly higher(P = 0.021).The expression of FUNDC1 in advanced ovarian cancer tissues(stage Ⅲ/ Ⅳ) was significantly higher that in early stage ovarian cancer tissues(stage Ⅰ/ Ⅱ) and the difference was statistically significant(P = 0.012).After the FUNDC1 gene of ovarian cancer cell SKOV3 was silenced,the abilities of proliferation(P = 0.032) and invasion(P = 0.035) of ovarian cancer cells decreased.Cells at S phase decreased significantly(P = 0.015) and expressions of p21 and p53 proteins up-regulated.Conclusion The expression of FUNDC1 protein in ovarian cancer tissues is up-regulated.The regulation of proliferation of ovarian cancer cell SKO V3 by FUNDC 1 may be relevant to p21/p53 pathway.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第2期218-223,共6页 Journal of Shanghai Jiao tong University:Medical Science
关键词 FUNDC1 卵巢癌 增殖 侵袭 FUNDC1 ovarian cancer proliferation invasion
  • 相关文献

参考文献23

  • 1波蒂,昌晓红,沈丹华,鲍冬梅,成夜霞,程红艳,叶雪,崔恒.卵巢癌的二元论模型研究进展[J].中华妇产科杂志,2011,46(10):789-791. 被引量:10
  • 2王登凤,张国楠.卵巢癌的输卵管起源学说对妇科手术决策的影响[J].中国实用妇科与产科杂志,2014,30(3):176-179. 被引量:4
  • 3于风胜,李艺,崔恒.卵巢癌干细胞及卵巢癌治疗[J].中国实用妇科与产科杂志,2014,30(1):14-17. 被引量:10
  • 4He Q, Man L, Ji Y, et al. Comparison in the biological characteris- tics between primary cultured sensory and motor Schwann cells[ J]. Neurosci Lett, 2012, 521(1): 57-61.
  • 5Salic A, Mitchison TJ. A chemical method for fast and sensitive detection of DNA synthesis in vivo[ J]. Proc Natl Acad Sci U S A, 2008,105(7) : 2415 -2420.
  • 6Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [ J]. CA Cancer J Clin, 2013, 63 (1) : 11 - 30.
  • 7Riahi A, Kharrat M, Lariani I, el al. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families [ J ]. Faro Cancer, 2014, 13(4) : 603 -609.
  • 8De A, De A, Papasian C, et al. Embliea offieinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors [ J ]. PLoS One, 2013, 8(8): e72748.
  • 9Xie X, Bartholomeusz C, Ahmed AA, et al. Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP [ J ]. Mol Cancer Ther, 2013, 12(6): 1099-1111.
  • 10Feng D, Liu L, Zhu Y, et al. Molecular signaling toward mitophagy and its physiological significance [ J ]. Exp Cell Res, 2013, 319 (12) : 1697 -1705.

二级参考文献42

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin,2009,59:225-249.
  • 2Singer G, Kurman R J, Chang HW, et al. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol, 2002, 160 : 1223-1228.
  • 3Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol,2004,164 : 1511-1518.
  • 4Malpica A, Deavers MT, Tornos C, et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol,2007,31 : 1168-1174.
  • 5FIGO Cancer Committee. Staging Announcement. West Berlin. 1985. Gvnecol Oncol. 1986.25:383.
  • 6Plaxe SC. Epidemiology of low-grade serous ovarian cancer. Am J Obstet Gyneco1,2008 ,198 :459.
  • 7May T, Virtanen C, Sharma M, et al. Low malignant potential tumors with micropapillary features are molecularly similar to low- grade serous carcinoma of the ovary. Gynecol Oncol,2010,117:9- 17.
  • 8Cho YH, Kim DY, Kim JH, et al. Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women. Yonsei Med J,2009,50:266-272.
  • 9Schlosshauer PW, Deligdisch L, Penault-Llorca F, et al. Loss of pl6INK4A expression in low-grade ovarian serous carcinomas. Int J Gynecol Pathol,2011,30 :22-29.
  • 10O'Neill C J, Deavers MT, Malpica A, et al. An immunohistochemical comparison between low-grade and high- grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol,2005,29 : 1034-1041.

共引文献21

同被引文献41

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部